Ron N. Apte
Beersheba, D, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Corrigendum to "Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells" [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549-562].
Journal: Neoplasia (New York, N.Y.)
Published: December 29, 2024
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment.
Journal: International journal of molecular sciences
Published: February 25, 2024
Salmonella manipulates the host to drive pathogenicity via induction of interleukin 1β.
Journal: PLoS biology
Published: December 12, 2023
Gene deletion of Interleukin-1α reduces ER stress-induced CHOP expression in macrophages and attenuates the progression of atherosclerosis in apoE-deficient mice.
Journal: Cytokine
Published: December 06, 2022
Tryptophol Acetate and Tyrosol Acetate, Small-Molecule Metabolites Identified in a Probiotic Mixture, Inhibit Hyperinflammation.
Journal: Journal of innate immunity
Published: November 02, 2022
Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α-STAT3 Axis.
Journal: Cancer immunology research
Published: March 18, 2022
Pathogenetic role and clinical significance of interleukin-1β in cancer.
Journal: Immunology
Published: December 10, 2021
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity.
Journal: Scientific reports
Published: August 05, 2020
Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction.
Journal: Journal of molecular and cellular cardiology
Published: April 28, 2020
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy.
Journal: Molecular cancer research : MCR
Published: May 09, 2019
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 14, 2018
Last Updated: 09/26/2026